According to Divis Laboratories's latest financial reports the company's current EPS (TTM) is NZ$1.42. In 2025 the company made an earnings per share (EPS) of NZ$1.62 an increase over its 2024 EPS that were of NZ$1.21.
Year | EPS | Change |
---|---|---|
2025 | NZ$1.62 | 33.56% |
2024 | NZ$1.21 | -13.53% |
2023 | NZ$1.40 | -43.09% |
2022 | NZ$2.47 | 43.87% |
2021 | NZ$1.71 | 48.34% |
2020 | NZ$1.15 | -6.22% |
2019 | NZ$1.23 | 44.63% |
2018 | NZ$0.85 | -17.61% |
2017 | NZ$1.03 | -3.78% |
2016 | NZ$1.07 | 24.33% |
2015 | NZ$0.86 | 6.03% |
2014 | NZ$0.81 | 16.24% |
2013 | NZ$0.70 | 5.7% |
2012 | NZ$0.66 | 8.37% |
2011 | NZ$0.61 | 24.59% |
2010 | NZ$0.49 | -8.08% |
2009 | NZ$0.53 | -5.19% |
2008 | NZ$0.56 | 100.08% |
2007 | NZ$0.28 | 177.51% |
2006 | NZ$0.10 |